Data / Form D filings / Receptor Life Sciences, Inc.
Receptor Life Sciences, Inc.: Form D filings
Receptor Life Sciences, Inc., a company in Seattle, WA, filed 2 Form D notices with the SEC between 2017 and 2018. The latest, on October 4, 2018, reports $7.6 million sold of a $7.6 million offering to 55 investors.
Find out what Receptor Life Sciences, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- C/O LANE POWELL PC, 1420 5TH AVE., SUITE 4200, Seattle, WA, 98101
- Phone
- (206) 483-2730
- Industry
- Other
- Entity type
- Corporation
- Incorporated in
- Washington
- Year incorporated
- 2015
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1693768
The full lists. Form D filings in Washington: 1,095 rows, $54.75, or the new rows each week for $19 a month. Form D filings in other industries: 9,873 rows, $178.73, or the new rows each week for $19.10 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 4, 2018 | Amendment | $7,574,970 | $7,574,970 | $0 | 55 | Dec 23, 2016 | sec.gov |
| Jan 6, 2017 | New notice | $6,250,000 | $2,525,000 | $3,725,000 | 21 | Dec 23, 2016 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Gregory Wesner | Director | |
| David Thomson | Director | |
| Arthur Rubinfeld | Director | |
| Traci Carman | Executive Officer, Director |
Other companies in Washington that filed recently
- SunFly Brands, Inc. $869,941 · Nov 9, 2026
- Legacy Venture Fund I, LLC $68 million · Nov 6, 2026
- NexLevel Cash Flow Holdings, LLC offering · Nov 3, 2026
- Awakened Grains LLC offering · Oct 28, 2026
- RBC Network Services Corp. $10 million · Oct 28, 2026
- Cliffview Power LLC $1,000 · Oct 27, 2026
- Harmony Apartments Opportunity Fund, LP $1.1 million · Oct 23, 2026
- WaveDivision Capital XIX, LLC $163 million · Oct 21, 2026
- Sports Innovation Group Inc. $975,000 · Oct 19, 2026
- Nordic 15 LLC offering · Oct 2, 2026
- ZIN BOATS, INC. offering · Sep 28, 2026
- Meadow AI, Inc. $13.1 million · Sep 25, 2026
- True Collective LLC $3.8 million · Sep 23, 2026
- Shoot 360 Inc. $4.8 million · Sep 21, 2026
- North40 Capital Growth Fund II LLC $100,000 · Sep 16, 2026
Every Form D from the week of Oct 1, 2018 · All recent filings in Washington · All recent Other filings
Read from SEC EDGAR. Amount sold is what Receptor Life Sciences, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.